Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”-Reference-Cited by-同舟云学术

Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”

Published:2014 Issue:10 Volume:112 Page:841-841
ISSN:0340-6245
Container-title:Thrombosis and Haemostasis
language:en
Short-container-title:Thromb Haemost

Author:

Crowther Mark,Burnett Allison,Garcia David,Kaatz Scott,Lopes Renato,Nutescu Edith,Oertel Lynn,Schnurr Terri,Streiff Michael,Wirth Diane,Witt Daniel,Wittkowsky Ann,Ansell Jack,

Publisher

Georg Thieme Verlag KG

Subject

Hematology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1160/TH14-04-0325.pdf

Reference2 articles.

1. Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

2. ISMP Medication Safety Alert, December 12, 2013; Volume 18, issue 25

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention;F1000Research;2016-12-20

2. Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease;Current Medicinal Chemistry;2016-07-19

3. Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: reply;Journal of Thrombosis and Haemostasis;2015-09-30

4. Dabigatran in ‘real-world’ clinical practice for stroke prevention in patients with non-valvular atrial fibrillation;Thrombosis and Haemostasis;2015

5. Response to Ansell et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”;Thrombosis and Haemostasis;2014